ArticleJournal of clinical microbiology2026
Evaluation of Chagas TESA VirClia assay for chronic
Aroa Silgado, Alejandro Mediavilla, Patricia Martínez-Vallejo, Pau Bosch-Nicolau, Carles Rubio-Maturana, Lidia Goterris, Inés Oliveira-Souto, Núria Serre-Delcor, Joan Joseph-Munné, Israel Molina and 1 more
Abstract readEvaluation Study
In one paragraphArticle in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Aroa SilgadoDepartment of Microbiology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain.ORCID 0000-0001-7581-0049 Alejandro MediavillaDepartment of Microbiology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain.
Patricia Martínez-VallejoDepartment of Microbiology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain.
Pau Bosch-NicolauCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Carles Rubio-MaturanaDepartment of Microbiology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain.ORCID 0000-0002-5615-9278 Lidia GoterrisDepartment of Microbiology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain.
Inés Oliveira-SoutoCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Núria Serre-DelcorCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Joan Joseph-MunnéDepartment of Microbiology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain.
Israel MolinaCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Elena SulleiroDepartment of Microbiology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain.ORCID 0000-0002-9783-6060 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Indexed as
Antibodies, ProtozoanAntigens, ProtozoanChagas DiseaseLuminescent MeasurementsTrypanosoma cruziAdultChronic DiseaseFemaleFollow-Up StudiesHumansMaleMiddle AgedRetrospective StudiesSensitivity and SpecificitySerologic TestsAntibodies, ProtozoanAntigens, Protozoanchronic Chagas diseaseCLIA assayserological diagnosticsTESA antigenTrypanosoma cruzi
Identifiers
PMID42284051
PMCPMC13343857
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390